मूलभूत आँकड़े
| CIK | 1307624 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Healthtech Solutions Inc.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| June 13, 2025 |
Exhibit 10.2 FIRST AMENDMENT DATED JUNE 5, 2025 MODIFYING THE EXECUTIVE EMPLOYMENT AGREEMENT DATED JANUARY 27, 2023 BETWEEN HEALTHTECH SOLUTIONS, INC. AND JAMES PESOLI This First Amendment (this “First Amendment”) is made and entered into as of June 5, 2025 (the “Effective Date”) by and between Healthtech Solutions, Inc. (“Company”) and James Pesoli (“Executive”). Company and Executive may sometim |
|
| June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 13, 2025 |
Exhibit 2.1 Execution Version PATENT PURCHASE AGREEMENT This PATENT PURCHASE AGREEMENT (“Agreement”) is entered into and made effective as of June 5, 2025 (the “Effective Date”), by and between Papyrus Therapeutic LLC, a Delaware limited liability company (“Purchaser”), and Healthtech Solutions, Inc., a Utah corporation (“Seller” and together with Purchaser, the “Parties”). R E C I T A L S WHEREAS |
|
| June 13, 2025 |
MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT “World Reach Holdings, LLC” Exhibit 2.2 Execution Version MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT “World Reach Holdings, LLC” This Membership Interest Purchase and Sale Agreement (this “Agreement”) is made and entered into as of June 5, 2025 (the “Effective Date”), by and among Healthtech Solutions, Inc. (“HLTT”), a Utah corporation, Live For Today Ventures, LLC (“LFTV”), a Delaware limited liability company, and Red |
|
| June 13, 2025 |
Exhibit 10.1 Execution Version PATENT LICENSE AGREEMENT This Patent License Agreement (this “Agreement”) is entered into as of June 5, 2025 (the “Effective Date”), by and between Papyrus Therapeutic LLC (“Licensor”), a Delaware limited liability company, and Healthtech Wound Care, Inc. (“Licensee”), a Delaware corporation. Licensor and Licensee may sometimes be referred to herein individually as a |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2025 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or other jurisdiction (Commission (I.R.S. Employer |
|
| January 27, 2025 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for use of the Commission only [X] Definitive Information Statement Healthtech Solutions, Inc. |
|
| January 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2024 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| December 20, 2024 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [x] Preliminary Information Statement [ ] Confidential, for use of the Commission only [ ] Definitive Information Statement Healthtech Solutions, Inc. |
|
| September 6, 2023 |
AMENDED AND RESTATED BINDING AND CONFIDENTIAL TERM SHEET AMENDED AND RESTATED BINDING AND CONFIDENTIAL TERM SHEET This Amended and Restated Binding and Confidential Term Sheet (this “Term Sheet”) is dated August 18, 2023 (the “Effective Date”) and sets forth the basic terms of understanding between Healthtech Solutions, Inc. |
|
| September 6, 2023 |
MANUFACTURING AGREEMENT This Manufacturing Agreement (this “Agreement”) is entered into as of August 18, 2023 (the “Effective Date”), by and between Healthtech Wound Care, Inc. |
|
| September 6, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2023 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| July 28, 2023 |
HEALTHTECH SOLUTIONS, INC. COMMON STOCK REMOVED FROM THE OTC PINK MARKET HLTT Common Stock Is Now Available for Trading Exclusively on the OTC Expert Market Sales and Operations Remain Stable Tuckahoe NY — July 27, 2023 (OTC: HLTT) – Healthtech Solutions Inc., via its subsidiaries, researches, develops, manufacturers and commercializes a line of wound care products including DermaBind™, a dehydrat |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./U |
|
| June 28, 2023 |
MediScan, Inc., a Florida corporation EXHIBIT 21: SUBSIDIARIES OF THE COMPANY MediScan, Inc., a Florida corporation RevHeart, Inc., a Delaware corporation Healthtech Wound Care, Inc., a Delaware corporation Healthtech Management Services, LLC, a Utah limited liability company The Clia Lab, LLC, a Delaware limited liability company World Reach Holdings, LLC, a Delaware limited liability company World Reach Health, LLC, a Delaware limit |
|
| March 31, 2023 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2025 Washington, D. |
|
| March 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2023 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer o |
|
| February 2, 2023 |
Principal Amount: $1,393,869.00 USD Loan Date: December 31, 2022 SECURITY AGREEMENT This Security Agreement (this “Agreement”) is entered into as of January 27, 2023 (the “Effective Date”) between Healthtech Solutions, Inc. (“Borrower” or “Healthtech”), a Utah Corporation with a principal place of business located at 181 Dante Avenue, Tuckahoe, New York 10707, including, without limitation, Health |
|
| February 2, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 4 exh10d.htm EXHIBIT 10-D EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of January 27, 2023 (the "Effective Date") by and between Healthtech Solutions, Inc., a Utah corporation with a principal business address at 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and Jelena Olmstead, an individual residing in the state of |
|
| February 2, 2023 |
PROMISSORY NOTE (“Note”) Amount of Note: Date of Note: $1,393,689.00 USD December 31, 2022 (the “Effective Date”) FOR VALUE RECEIVED, the undersigned, Healthtech Solutions, Inc. (“Borrower” or “Healthtech”), a Utah Corporation with a principal place of business located at 181 Dante Avenue, Tuckahoe, New York 10707, hereby promises to pay to the order of World Reach Med, LLC (“Lender”), a Delaware |
|
| February 2, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 6 exh10f.htm EXHIBIT 10-F EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of January 27, 2023 (the "Effective Date") by and between Healthtech Solutions, Inc., a Utah corporation with a principal business address at 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and James Pesoli, an individual residing in the state of Fl |
|
| February 2, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 5 exh10e.htm EXHIBIT 10-E EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of January 27, 2023 (the "Effective Date") by and between Healthtech Solutions, Inc., a Utah corporation with a principal business address at 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and Manuel E. Iglesias, an individual residing in the state |
|
| February 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2023 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| January 6, 2023 |
EX-99 2 ex991.htm EXHIBIT 99.1 HEALTHTECH SOLUTIONS, INC. 181 Dante Avenue Tuckahoe, New York 10707 Annual letter to our shareholders and employees Greetings: As the new year emerges, I am using this occasion to reflect on the progress made by your company (“HLTT”) during 2022 and the prospects that we see for 2023. We ended 2021 as a medical technology incubator with only a series of scanning tec |
|
| January 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2023 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| December 22, 2022 |
EQUITY EXCHANGE AGREEMENT (this “Agreement”) EQUITY EXCHANGE AGREEMENT (this ?Agreement?) DATE: December 21, 2022 (the ?Effective Date?) PARTIES: ?HLTT? Healthtech Solutions, Inc. |
|
| December 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2022 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| November 23, 2022 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./UT (Exact Name of |
|
| November 14, 2022 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2025 Washington, D. |
|
| September 12, 2022 |
COMMON STOCK PURCHASE OPTION HEALTHTECH SOLUTIONS, INC. COMMON STOCK PURCHASE OPTION HEALTHTECH SOLUTIONS, INC. Option Holder: Storm Funding, LLC Grant Date: September 6, 2022 Option Shares: 15,000,000 Termination Date: September 5, 2025 Exercise Price: $0.25 (subject to adjustment) THIS COMMON STOCK PURCHASE OPTION (the ?Option?) certifies that, for value received, the Option Holder specified above or assigns (the ?Holder?) is entitled, upon the terms |
|
| September 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2022 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| August 19, 2022 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./UT (Exact Name of Regi |
|
| August 15, 2022 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D. |
|
| May 20, 2022 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./UT (Exact Name of Reg |
|
| May 16, 2022 |
NT 10-Q 1 hlttnt10q.htm NT 10-Q UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D.C. 20549 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-51012 NOTIFICATION OF LATE FILING CUSIP NUMBER 42227P103 (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR |
|
| April 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ?[?] ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 ?[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, |
|
| April 15, 2022 |
MediScan, Inc., a Florida corporation EXHIBIT 21: SUBSIDIARIES OF THE COMPANY MediScan, Inc., a Florida corporation RevHeart, Inc., a Delaware corporation Healthtech Wound Care, Inc., a Delaware corporation Healthtech Management Services, LLC, a Utah limited liability company 1 |
|
| April 15, 2022 |
EX-4 2 ex4.htm EXHIBIT 4VI EXHIBIT 4(iv) DESCRIPTION OF COMMON STOCK Our only class of security registered pursuant to Section 12(g) of the Securities Exchange Act is our common stock, $0.001 par value per share. 200,000,000 shares of common stock are authorized. Holders of our common stock are entitled to receive dividends when and as declared by our board of directors out of funds legally availa |
|
| March 31, 2022 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: March 31, 2022 Washington, D. |
|
| February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2022 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| February 3, 2022 |
EX-10 2 ex10b.htm EXHIBIT 10-B OPERATIONS AGREEMENT Date: January 28, 2022 Parties: “PTG” Predictive Technology Group, Inc., a Nevada corporation 615 Arapeen Drive, Suite 300, Salt Lake City, UT 84108 “PBI” Predictive Biotech, Inc., a Utah corporation 615 Arapeen Drive, Suite 300, Salt Lake City, UT 84108 “HLTT” Healthtech Solutions, Inc., a Utah corporation 181 Dante Avenue, Tuckahoe, NY 10707 “H |
|
| January 21, 2022 |
ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this "Agreement") is dated as of the 18th day of January 2022 (the "Effective Date"), by and among HEALTHTECH SOLUTIONS, INC. |
|
| January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2022 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| January 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| January 6, 2022 |
TERM SHEET ACQUISITION OF ASSETS OF PREDICTIVE BIOTECH BY HLTT AND RELATED TRANSACTIONS December 30, 2021 HLTT: Healthtech Solutions, Inc. |
|
| November 22, 2021 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./UT (Exact Name of |
|
| November 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| November 18, 2021 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [x] Preliminary Information Statement [ ] Confidential, for use of the Commission only [ ] Definitive Information Statement Healthtech Solutions, Inc. |
|
| November 18, 2021 |
State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37. |
|
| November 15, 2021 |
Share Exchange Agreement This Share Exchange Agreement, dated as of November 9, 2021 (this ?Agreement?), is by and among VARIAN BIOPHARMACEUTICALS INC. |
|
| November 15, 2021 |
TERMINATION AND MUTUAL RELEASE AGREEMENT EX-10 3 ex10b.htm EXHIBIT 10-B TERMINATION AND MUTUAL RELEASE AGREEMENT This TERMINATION AND MUTUAL RELEASE AGREEMENT dated November 9, 2021 (this “Agreement”), is made and entered into by and among HEALTHTECH SOLUTIONS, INC., a Utah corporation ("HLTT"), HEALTHTECH ONCOLOGY, INC., a Delaware corporation ("HoldCo") and VARIAN BIOPHARMACEUTICALS INC., a Delaware corporation (“Varian”). HLTT, HoldCo |
|
| November 15, 2021 |
NT 10-Q 1 hlttnt10q.htm NT 10-Q UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D.C. 20549 Estimated average burden Hours per response 2.5 FORM 12b-25 SEC FILE NUMBER 0-51012 NOTIFICATION OF LATE FILING CUSIP NUMBER 42227P103 (Check One): ¨ Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| November 4, 2021 |
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK] EX-10 2 ex10a.htm EXHIBIT 10-A PRIVATE AND CONFIDENTIAL October 29, 2021 Letter of Intent This letter of intent (this "LOI") sets out the understanding among the parties hereto of the principal terms on which HEALTHTECH SOLUTIONS, INC., a Utah corporation ("HLTT"), HEALTHTECH ONCOLOGY, INC., a Delaware corporation ("HoldCo"), and the individuals who were formerly shareholders of HoldCo (the "Share |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| September 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| August 25, 2021 |
EXHIBIT 32-a: Rule 13a-14(b) Certification of CEO EXHIBIT 32-a: Rule 13a-14(b) Certification of CEO Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthtech Solutions, Inc. (the “Company”) certifies that: 1. The Quarterly Report on Form 10-Q/A (Amendment No. 1) of the Company for the period ended June 30, 2021 (the “Report”) fully complies with the requirements |
|
| August 25, 2021 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q/A (Amendment No. 1) U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q/A (Amendment No. 1) ☑ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC./UT |
|
| August 25, 2021 |
EXHIBIT 31-b: Rule 13a-14(a) Certification of CFO EXHIBIT 31-b: Rule 13a-14(a) Certification of CFO I, Manuel Iglesias, certify that: 1. |
|
| August 25, 2021 |
EXHIBIT 32-b: Rule 13a-14(b) Certification of CFO EXHIBIT 32-b: Rule 13a-14(b) Certification of CFO Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthtech Solutions, Inc. (the “Company”) certifies that: 1. The Quarterly Report on Form 10-Q/A (Amendment No. 1) of the Company for the period ended June 30, 2021 (the “Report”) fully complies with the requirements |
|
| August 25, 2021 |
EXHIBIT 31-a: Rule 13a-14(a) Certification of CEO EXHIBIT 31-a: Rule 13a-14(a) Certification of CEO I, Edward Swanson, certify that: 1. |
|
| August 23, 2021 |
EXHIBIT 31-a: Rule 13a-14(a) Certification of CEO EXHIBIT 31-a: Rule 13a-14(a) Certification of CEO I, Edward Swanson, certify that: 1. |
|
| August 23, 2021 |
EXHIBIT 31-b: Rule 13a-14(a) Certification of CFO EXHIBIT 31-b: Rule 13a-14(a) Certification of CFO I, Manuel Iglesias, certify that: 1. |
|
| August 23, 2021 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q ☑ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0‑51012 HEALTHTECH SOLUTIONS, INC./UT (Exact Name of Regi |
|
| August 23, 2021 |
EXHIBIT 32-b: Rule 13a-14(b) Certification of CFO EXHIBIT 32-b: Rule 13a-14(b) Certification of CFO Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthtech Solutions, Inc. (the “Company”) certifies that: 1. The Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or |
|
| August 23, 2021 |
EXHIBIT 32-a: Rule 13a-14(b) Certification of CEO EXHIBIT 32-a: Rule 13a-14(b) Certification of CEO Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Healthtech Solutions, Inc. (the “Company”) certifies that: 1. The Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or |
|
| August 16, 2021 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D. |
|
| August 12, 2021 |
EX-99 2 ex991.htm EXHIBIT 99.1 |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| July 26, 2021 |
Varian Biopharmaceuticals Inc. Financial Statements For Year Ended December 31, 2020 and From Inception (July 1, 2019) to December 31, 2019 Varian Biopharmaceuticals, Inc. For the Year Ended December 31, 2020 and From Inception (July 1, 2019) to December 31, 2019 INDEX Report of Independent Registered Public Accountants 1-2 Consolidated Balance Sheets 3 Consolidated Statements of Operations 4 Cons |
|
| July 26, 2021 |
UNAUDITED PRO FORMA COMBINED BALANCE SHEET UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION FOR THE YEAR ENDED DECEMBER 31, 2020 AND THE THREE MONTHS ENDED MARCH 31, 2021 On May 7, 2021 HLTT Acquisition Corp. |
|
| July 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission ( |
|
| July 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| July 22, 2021 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 2 ex10a.htm EXHIBIT 10-A EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of the 19th day of July, 2021 by and between Healthtech Solutions, Inc., a corporation with a principal business address of 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and Manuel E. Iglesias, an individual residing in the state of Florida (“Executive” |
|
| July 19, 2021 |
EX-10 2 ex10a.htm EXHIBIT 10-A DIRECTOR AGREEMENT This DIRECTOR AGREEMENT (the “Agreement”) is dated July 13, 2021 by and between HEALTHTECH SOLUTIONS, INC., a Utah corporation (the “Company”), and PAUL MANN, an individual resident of the State of Florida (the “Director”). WHEREAS, the Company appointed the Director effective as of the date hereof (the “Effective Date”) and desires to enter into a |
|
| July 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| July 19, 2021 |
EX-10 3 ex10b.htm EXHIBIT 10-B CONSULTING AGREEMENT This CONSULTING AGREEMENT (the “Agreement”) is dated July 13, 2021 (the "Effective Date") by and between HEALTHTECH SOLUTIONS, INC., a Utah corporation (the “Company”), and PAUL MANN, an individual resident of the State of Florida (the “Consultant”). WHEREAS, the Company desires to obtain the technological and scientific services of the Consultan |
|
| July 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| July 8, 2021 |
EX-10 2 ex10a.htm EXHIBIT 10-A DIRECTOR AGREEMENT This DIRECTOR AGREEMENT (the “Agreement”) is dated July 2, 2021 by and between HEALTHTECH SOLUTIONS, INC., a Utah corporation (the “Company”), and STEVEN A. HOROWITZ, an individual resident of the State of New York (the “Director”). WHEREAS, the Company appointed the Director effective as of the date hereof (the “Effective Date”) and desires to ent |
|
| July 8, 2021 |
Healthtech Solutions, Inc. Adds Distinguished Leadership To Its Board of Directors Steve Horowitz appointed to Board of Directors Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from pre-clinical |
|
| July 8, 2021 |
EX-10 3 ex10b.htm EXHIBIT 10-B HEALTHTECH SOLUTIONS INC. SHARE UNIT GRANT AGREEMENT (PERFORMANCE VESTING) (PERFORMANCE RESTRICTED SHARE UNITS) The following Award is given to the Participant identified below pursuant to the Company's undertaking in the following agreement: Executive Employment Agreement dated June 28, 2021 between Healthtech Solutions, Inc. and Edward Swanson (the "Employment Agre |
|
| July 8, 2021 |
EX-10 4 ex10c.htm EXHIBIT 10-C HEALTHTECH SOLUTIONS INC. SHARE UNIT GRANT AGREEMENT (PERFORMANCE VESTING) (PERFORMANCE RESTRICTED SHARE UNITS) The following Award is given to the Participant identified below pursuant to the Company's undertaking in the following agreement: Executive Employment Agreement dated June 28, 2021 between Healthtech Solutions, Inc. and Bradley K. Mathis (the "Employment A |
|
| July 1, 2021 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 4 ex10c.htm EXHIBIT 10C EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of the 28 day of June, 2021 by and between Healthtech Solutions, Inc., a corporation with a principal business address of 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and Bradley K. Mathis, an individual residing in the state of Pennsylvania (“Executive |
|
| July 1, 2021 |
EX-99 5 ex991.htm EXHIBIT 99.1 Healthtech Solutions, Inc. Bolsters Management and Board with Two New Appointments Brad K. Mathis appointed as Chief Operating Officer Ryan Salomone appointed to Board of Directors NEW YORK (July 1, 2021) - via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), an innovative portfolio-model life sciences company focused on building |
|
| July 1, 2021 |
DIRECTOR AGREEMENT This DIRECTOR AGREEMENT (the ?Agreement?) is dated June 28, 2021 by and between HEALTHTECH SOLUTIONS, INC. |
|
| July 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2021 HEALTHTECH SOLUTIONS, INC./UT (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| July 1, 2021 |
EXECUTIVE EMPLOYMENT AGREEMENT EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?) is made and entered into as of the 28th day of June, 2021 (the "Effective Date") by and between Healthtech Solutions, Inc. |
|
| May 24, 2021 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HEALTHTECH SOLUTIONS, INC. (Exact Name of Re |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of Inc |
|
| May 17, 2021 |
EX-99 3 ex99.htm EXHIBIT 99 Healthtech Solutions, Inc. (HLTT), Parent Company of Varian Biopharmaceuticals Inc, Medi-Scan Inc. and RevHeart Inc., Announces the Appointment of Edward Swanson, MD as New Chief Executive Officer Healthtech Solutions, Inc. (OTC: HLTT) (“Healthtech” or the “Company”), announced today that Edward (Ned) Swanson, M.D., was named Chief Executive Officer. Dr. Swanson has a u |
|
| May 17, 2021 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: February 28, 2022 Washington, D. |
|
| May 17, 2021 |
EXECUTIVE EMPLOYMENT AGREEMENT EX-10 2 ex10a.htm EXHIBIT 10-A EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into as of the 14th day of May, 2021 (the "Effective Date") by and between Healthtech Solutions, Inc. a Utah corporation with a principal business address at 181 Dante Avenue, Tuckahoe, NY 10707 (the “Company”) and Edward Swanson, an individual residing in the state o |
|
| May 12, 2021 |
State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37. |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of Inco |
|
| May 12, 2021 |
Varian Biopharmaceuticals Inc. Financial Statements For Year Ended December 31, 2020 and From Inception (July 1, 2019) to December 31, 2019 Varian Biopharmaceuticals, Inc. For the Year Ended December 31, 2020 and From Inception (July 1, 2019) to December 31, 2019 INDEX Report of Independent Registered Public Accountants 1-2 Consolidated Balance Sheets 3 Consolidated Statements of Operations 4 Cons |
|
| April 29, 2021 |
8-K 1 hltt8k42421.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (C |
|
| April 1, 2021 |
EX-10 2 ex10.htm EXHIBIT 10-A AGREEMENT AND PLAN OF MERGER AND REORGANIZATION BY AND AMONG HEALTHTECH SOLUTIONS, INC. HLTT ACQUISITION INC., HEALTHTECH ONCOLOGY, INC. AND VARIAN BIOPHARMACEUTICALS INC. Dated as of March 30, 2021 TABLE OF CONTENTS MERGER 1 1.1. The Share Exchange 1.2 The Merger 2 1.3. The Effective Time of the Merger 2 1.4. Effect of Merger 2 1.5. Certificate of Formation and Oper |
|
| April 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of I |
|
| April 1, 2021 |
Healthtech Solutions, Inc. Announces Contract to Acquire Varian Biopharmaceuticals, A Precision Oncology Company Initial Acquisition in the Oncology Therapeutic Space for HLTT subsidiary, Healthtech Oncology, Inc. Varian Biopharmaceuticals is Developing a Proprietary atypical Protein Kinase C iota Inhibitor in Multiple Formulations for A Broad Range of Tumor Types NEW YORK (March 31, 2021) - via I |
|
| March 10, 2021 |
8-K 1 hltt8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commiss |
|
| March 10, 2021 |
State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37. |
|
| March 8, 2021 |
- CONSENT OF PRAGER METIS CPA'S LLC CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the inclusion in this Offering Statement of Healthtech Solutions, Inc. |
|
| March 8, 2021 |
PART II AND III 2 hlttcircular.htm PART II AND III As submitted to the Securities and Exchange Commission on March 8, 2021 PART II – INFORMATION REQUIRED IN OFFERING CIRCULAR Preliminary Offering Circular dated March 8, 2021 An Offering Statement pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission. Information contained in this Prelimina |
|
| March 8, 2021 |
- REGULATION A SUBSCRIPTION AGREEMENT HEALTHTECH SOLUTIONS, INC. SUBSCRIPTION AGREEMENT NOTICE TO INVESTORS THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. THERE IS NO MARKET FOR RESALE OF THE SERIES B PREFERRED STOCK OFFERED, AND THE MARKET FOR THE SHARES OF COMMON STOCK INTO |
|
| March 2, 2021 |
EX-3 2 ex3a3.htm ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION FILED ON NOVEMBER 6, 2020 State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37.00 Pursuant to UCA §16-10a part 10, the individual named below causes this Amendment to the Articles of |
|
| March 2, 2021 |
10-K 1 hltt12312010k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [√] ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File N |
|
| February 22, 2021 |
EX-3 2 ex3a.htm ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION FILED ON FEBRUARY 16, 2021 State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37.00 Pursuant to UCA §16-10a part 10, the individual named below causes this Amendment to the Articles of |
|
| February 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2021 HEALTHTECH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer o |
|
| December 8, 2020 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for use of the Commission only [X] Definitive Information Statement HYB Holding Corp. |
|
| November 24, 2020 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for use of the Commission only [ ] Definitive Information Statement HYB Holding Corp. |
|
| November 24, 2020 |
HYBG / HYB Holding Corp. / Rubin David - SC 13D/A Activist Investment SC 13D/A 1 sch13da1.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a) (Amendment No. 1) HYB HOLDING CORP. (Name of Issuer) Common Stock (Title of Class of Securities) 44861C109 (CUSIP Number) DAVID RUBIN 90 Broad Street, 16 |
|
| November 16, 2020 |
HYB HOLDING CORP. 7% Convertible Debenture NEITHER THIS DEBENTURE NOR THE SECURITIES INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. |
|
| November 16, 2020 |
State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37. |
|
| November 16, 2020 |
SHARE EXCHANGE AGREEMENT by and among HYB Holding Corp. a Utah corporation and Medi-Scan, Inc. a Florida corporation and the Shareholders of Medi-Scan, Inc. Dated as of November 12, 2020 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT (hereinafter referred to as this “Agreement”) is entered into as of this 12th day of November, 2020, by and among HYB Holding Corp., a Utah corporation (“HYB |
|
| November 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 HYB HOLDING CORP. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorpo |
|
| November 16, 2020 |
TECHNOLOGY ASSIGNMENT AGREEMENT TECHNOLOGY ASSIGNMENT AGREEMENT This TECHNOLOGY ASSIGNMENT AGREEMENT (the "Agreement") is made and effective December 18, 2018, BETWEEN: RICHARD PARKER, 6 SIGMA, LLC, including all related, subsidiary, affiliated entities, or persons or otherwise related to or controlled (the "Assignor'' or "Assignors"), with his or its head office located at: 6118 Dusenburg Road Delray Beach, FL 33484 AND: MEDI-S |
|
| October 23, 2020 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HYB HOLDING CORP. (Exact Name of Registr |
|
| September 30, 2020 |
SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for use of the Commission only [ ] Definitive Information Statement HYB Holding Corp. |
|
| September 28, 2020 |
HYBG / HYB Holding Corp. / Rubin David - SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| September 11, 2020 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: September 4, 2020 HYB HOLDING CORP. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State of other jurisdiction of (Commission File No.) (IRS Employer incorporation or organization Identification No. |
|
| September 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED JUNE 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 HYB HOLDING CORP. (Exact Name of Re |
|
| July 1, 2020 |
Changes in Registrant's Certifying Accountant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 26, 2020 HYB HOLDING CORP. (Exact name of registrant as specified in its charter) Utah 0-51012 84-2528660 (State of other jurisdiction of (Commission File No.) (IRS Employer incorporation or organization Identification No.) 52 |
|
| April 28, 2020 |
Summary of Oral Agreement dated July 31, 2017 between Robert Brantl and HYB Holding Corp. HYB HOLDING CORP. Summary of Oral Agreement re Loans THE FOLLOWING IS A SUMMARY OF THE MATERIAL TERMS OF AN ORAL AGREEMENT MADE ON JULY 31, 2017 BETWEEN ROBERT BRANTL AND HYB HOLDING CORP. THE AGREEMENT REMAINS IN EFFECT AS OF APRIL 28, 2020. Parties: Brantl Robert Brantl 52 Mulligan Lane, Irvington, NY 10533 Company HYB Holding Corp. 52 Mulligan Lane, Irvington, NY 10533 Terms: A. Brantl will, fr |
|
| April 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10/A (Amendment No. |
|
| April 28, 2020 |
HYB HOLDING CORP. 52 Mulligan Lane Irvington, NY 10533 914-693-3026 April 28, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Edward M. Kelly, Esq. Sherry Haywood, Esq. Charles Eastman Jean C. Yu Re: HYB Holding Corp. Amendment No. 2 to Registration Statement on Form 10-12G Filed April 28, 2020 File No. 0-5101 |
|
| April 20, 2020 |
HYB HOLDING CORP. 52 Mulligan Lane Irvington, NY 10533 914-693-3026 April 20, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Edward M. Kelly, Esq. Sherry Haywood, Esq. Charles Eastman Jean C. Yu Re: HYB Holding Corp. Amendment No. 1 to Registration Statement on Form 10 Filed April 20, 2020 File No. 0-51012 La |
|
| April 20, 2020 |
XNYH / Xinyinhai Technology, Ltd. 10-12G/A - - FORM 10-12G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10 /A (Amendment No. |
|
| March 19, 2020 |
Articles of Amendment to Articles of Incorporation filed on September 27, 2006 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF IRON STAR DEVELOPMENT, INC. The Articles of Incorporation of Iron Star Development, Inc., a Utah corporation (the "Corporation") are hereby amended pursuant to the Section 16-10a-1066 of the Utah Code as follows: 1. The name of the Corporation is Iron Star Development, Inc. 2. The Articles of Incorporation of the Corporation are hereby amended |
|
| March 19, 2020 |
Articles of Amendment to Articles of Incorporation filed on June 28, 2019 State of Utah DEPARTMENT OF COMMERCE Division of Corporations & Commercial Code Articles of Amendment to Articles of Incorporation (Profit) Entity Number: 913097-0142 Non-Refundable Processing Fee: $37. |
|
| March 19, 2020 |
Restated Articles of Incorporation filed on July 12, 2004 RESTATED ARTICLES OF INCORPORATION OF BRITTANY DEVELOPMENT, INC. Brittany Development, Inc., a Utah corporation, (the "Company") restates it Articles of Incorporation pursuant to the provisions of Section 16-10a-1007 of the Utah Code and such Restatement was approved by Shareholder Action without a meeting on June 23, 2004, upon which date sufficient shares were present and voting to adopt the Res |
|
| March 19, 2020 |
XNYH / Xinyinhai Technology, Ltd. 10-12G - - FORM 10-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 HYB Holding Corp. |
|
| March 19, 2020 |
Bylaws - as amended on June 25, 2019 BYLAWS of HYB HOLDING CORP. ARTICLE I: OFFICE Section 1.1 Office. The Corporation shall maintain such offices, within or without the State of Utah, as the Board of Directors may designate. The Board of Directors has the power to change the location of the principal office. ARTICLE II: SHAREHOLDERS’ MEETING Section 2.1 Annual Meetings. The annual meeting of the shareholders of the Corporation shall |
|
| March 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its |
|
| March 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: March 1, 2012 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of other jurisdiction of (IRS Employer incorporation or organization |
|
| February 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K /A (Amendment No. 1) (Mark one) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0- |
|
| February 21, 2012 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q /A (Amendment No. 1) U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q /A (Amendment No. 1) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOG |
|
| January 11, 2012 |
XINYINHAI TECHNOLOGY, LTD. No. 16 Dalian Road, Haping Road Centralized Industrial Park, Harbin Development Zone P.R. China 150060 January 11, 2012 VIA EDGAR Linda Cvrkel Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Washington, DC 20549 Re: Xinyinhai Technology, Ltd. Form 10-K for the Year Ended December 31, 2010 Filed April 13, 2011 Form 10-Q for the Quart |
|
| November 14, 2011 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name o |
|
| August 15, 2011 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of Reg |
|
| May 23, 2011 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of Re |
|
| May 16, 2011 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: May 31, 2012 Washington, D. |
|
| April 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-51012 XINYINHAI TECHN |
|
| March 31, 2011 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: May 31, 2012 Washington, D. |
|
| November 12, 2010 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name o |
|
| August 16, 2010 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of Reg |
|
| May 17, 2010 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of Re |
|
| March 31, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) |X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2009 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-51012 XINYINHAI TE |
|
| March 9, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark one) |X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2008 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: |
|
| January 8, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark one) |X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2008 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: |
|
| November 16, 2009 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name o |
|
| September 24, 2009 |
XINYINHAI TECHNOLOGY, LTD. No. 16 Dalian Road, Haping Road Centralized Industrial Park, Harbin Development Zone P.R. China 150060 September 24, 2009 VIA EDGAR Linda Cvrkel Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Washington, DC 20549 Re: Xinyinhai Technology, Ltd. Form 10-K for the fiscal year ended December 31, 2008 File No. 000-51012 Dear Ms. Cvrkel: |
|
| September 16, 2009 |
XINYINHAI TECHNOLOGY, LTD. No. 16 Dalian Road, Haping Road Centralized Industrial Park, Harbin Development Zone P.R. China 150060 September 16, 2009 VIA EDGAR Linda Cvrkel Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Washington, DC 20549 Re: Xinyinhai Technology, Ltd. Form 10-K for the fiscal year ended December 31, 2008 File No. 000-51012 Dear Ms. Cvrkel: |
|
| August 14, 2009 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of Reg |
|
| July 14, 2009 |
XINYINHAI TECHNOLOGY, LTD. No. 16 Dalian Road, Haping Road Centralized Industrial Park, Harbin Development Zone P.R. China 150060 July 14, 2009 VIA EDGAR Linda Cvrkel Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Washington, DC 20549 Re: Xinyinhai Technology, Ltd. Form 10-K for the fiscal year ended December 31, 2008 File No. 000-51012 Dear Ms. Cvrkel: I am |
|
| June 29, 2009 |
XINYINHAI TECHNOLOGY, LTD. No. 16 Dalian Road, Haping Road Centralized Industrial Park, Harbin Development Zone P.R. China 150060 June 29, 2009 VIA EDGAR Linda Cvrkel Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Washington, DC 20549 Re: Xinyinhai Technology, Ltd. Form 10-K for the fiscal year ended December 31, 2008 File No. 000-51012 Dear Ms. Cvrkel: I am |
|
| May 14, 2009 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Exact Name of |
|
| March 31, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) |X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2008 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-510 |
|
| December 10, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: December 5, 2008 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of other jurisdiction of (IRS Employer incorporation or organizati |
|
| November 14, 2008 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of Sm |
|
| August 22, 2008 |
Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: August 18, 2008 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of Other Jurisdiction of incorporation or organization) (I.R.S. Emp |
|
| August 14, 2008 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of Small Bus |
|
| June 17, 2008 |
8-K 1 xinyin8kchengxu61308.htm XINYINHAI 8-K - CHENGXU 6.13.08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: June 13, 2008 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of Oth |
|
| May 16, 2008 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q/A (Amendment No. 1) U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q/A (Amendment No. 1) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, |
|
| May 15, 2008 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of Small |
|
| April 14, 2008 |
BYLAWS XINYINHAI TECHNOLOGY, LTD. ARTICLE I: OFFICE Bylaws OF BYLAWS of XINYINHAI TECHNOLOGY, LTD. ARTICLE I: OFFICE Section 1.1 Office. The Corporation shall maintain such offices, within or without the State of Utah, as the Board of Directors may designate. The Board of Directors has the power to change the location of the principal office. ARTICLE II: SHAREHOLDERS’ MEETING Section 2.1 Annual Meetings. The annual meeting of the shareholders of th |
|
| April 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB (Mark One) [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE FISCAL YEAR ENDED DECEMBER 31, 2007 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number: 0-5 |
|
| April 7, 2008 |
Converted by EDGARwiz As filed with the Securities and Exchange Commission on April 7, 2008 Registration Number: 333-137516 SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 7, 2008 |
As filed with the Securities and Exchange Commission on April 7, 2008 Registration Number: 333-137918 SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 31, 2008 |
No. 16 Dalian Road, Centralized Park Haping Road, Harbin Development Zone, P.R. China 150060 SECURITIES & EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Notification of Late Filing XINYINHAI TECHNOLOGY, LTD. Commission File Number 0-51012 (Check one) [X] Form 10-K and Form 10-KSB [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR [ ] Form N-CSR For the period ended: December 31, 2007 [ ] Transition Report on Form 10-K and Form 10-KSB [ ] Transition Report on |
|
| December 21, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: December 18, 2007 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of other jurisdiction of (IRS Employer incorporation or organizat |
|
| December 21, 2007 |
Real Estate Purchase Contract Party A: Harbin Itokin Garments Co., Ltd Party B: Harbin Golden Sea Technology Printing Co., Ltd. In order to guarantee the legal benefits of both parties, issues concerning the building purchasing are entered into as follows: I. In accordance with the negotiation between both parties, Party A agrees to sell the building and land, which is located in No.4, Yantai Stre |
|
| November 7, 2007 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of |
|
| October 26, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: October 18, 2007 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of Other Jurisdiction of incorporation or organization) (I.R.S. Em |
|
| October 26, 2007 |
EX-10 2 xinyin8krealestateexh10a.htm XINYINHAI 8K - REAL ESTATE EXH 10-A Real Estate Purchase Contract Part A: Harbin ShunMai Real Estate Development Co.,Ltd Part B: Harbin Golden Sea Technology Printing Co.,Ltd. PartA (Seller) agrees to sell and convey to Part B (Purchaser), and Part B (Purchaser) agrees to buy from Part A (Seller) the Property described below: I. Property: Part A agrees to sell |
|
| October 9, 2007 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: October 9, 2007 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of Other Jurisdiction of incorporation or organizatio |
|
| October 9, 2007 |
Xinyinhai Technology Ltd., Announces Five New Accounts Xinyinhai Technology Ltd Xinyinhai Technology Ltd., Announces Five New Accounts Initial Orders to Generate Sales of $640,250 Tuesday October 9, 7:30 am ET July and August Revenue Totals $2 Million HARBIN CITY, China-(BUSINESS WIRE)-Xinyinhai Technology, Ltd. (OTCBB: XNYH - News) today announced five new accounts that will generated $640,250 in initial sales orders for bank and savings books. The n |
|
| August 13, 2007 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of Small |
|
| May 21, 2007 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of Smal |
|
| April 17, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB (Mark one) |X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2006 or | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SEDCURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0- |
|
| December 20, 2006 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NO.: 0-51012 Date of Report: December 18, 2006 XINYINHAI TECHNOLOGY, LTD. (Exact name of registrant as specified in its charter) Utah 87-0427336 (State of Other Jurisdiction of incorporation or organization) (I.R.S. E |
|
| December 20, 2006 |
KEMPISTY & COMPANY KEMPISTY & COMPANY CERTIFIED PUBLIC ACCOUNTANTS, P.C. 15 Maiden Lane, Suite 1003 New York, NY 10038 Tel: (212) 406-7CPA (7272) Fax: (212) 513-1930 December 19, 2006 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 We have read Item 4.01(a) of Form 8-K dated December 18, 2006 of Xinyinhai Technology, Ltd. and are in agreement with the statements co |
|
| November 20, 2006 |
U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB U U. S. Securities and Exchange Commission Washington, D. C. 20549 FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-51012 XINYINHAI TECHNOLOGY, LTD. (Name of |
